Bloomberg LP has built a significant media business spanning television, digital, magazine, radio and live event platforms across the globe. In the midst of a historic time in the media industry, Bloomberg Media is growing its global footprint and reach through new innovations from Quicktake to New Economy to our rapidly growing consumer subscription business.
The Bloomberg Opinion pharma writer will produce commentary and analysis about drug and biotech companies, identifying the most important themes and ideas at the intersection of science and business. This will entail looking at products, corporate strategies and political interests — as well as the regulatory agencies that monitor them, and their influence on people’s lives.
The person will also cover bioscience generally, drug innovation and issues in public health. Knowledge of markets, investing and the financial world will be important to this beat.
To apply, go here.
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…
The Financial Times has hired Barbara Moens to cover competition and tech in Brussels. She will start…
CNBC.com deputy technology editor Todd Haselton is leaving the news organization for a job at The Verge.…
Note from CNBC Business News senior vice president Dan Colarusso: After more than 27 years…